Skip to main content
. 2021 May 27;14:575–583. doi: 10.2147/JAA.S312123

Figure 2.

Figure 2

Effects of dupilumab on rate of patients on OCSs (A), OCSs dose (B) and FeNO values (C). The rate of patients on OCSs is expressed as a percentage (%) from the total. OCSs dose and FeNO values are expressed as median values and interquartile range (IQR). *p<0.05; **p<0.01; ****p<0.0001.

Abbreviations: OCSs, oral corticosteroids (prednisone); FeNO, fractional exhaled nitric oxide.